1. Home
  2. ARVN vs SSII Comparison

ARVN vs SSII Comparison

Compare ARVN & SSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

SELL

Current Price

$6.82

Market Cap

600.2M

Sector

Health Care

ML Signal

SELL

Logo SS Innovations International Inc.

SSII

SS Innovations International Inc.

HOLD

Current Price

$2.70

Market Cap

655.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARVN
SSII
Founded
2015
N/A
Country
United States
India
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
600.2M
655.3M
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
ARVN
SSII
Price
$6.82
$2.70
Analyst Decision
Buy
Analyst Count
16
0
Target Price
★ $13.93
N/A
AVG Volume (30 Days)
★ 772.6K
66.1K
Earning Date
11-04-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 58.84
45.45
EPS
★ 1.70
N/A
Revenue
★ $262,600,000.00
$42,484,747.00
Revenue This Year
$12.76
$40.29
Revenue Next Year
N/A
$27.85
P/E Ratio
$4.04
★ N/A
Revenue Growth
N/A
★ 105.74
52 Week Low
$6.80
$2.43
52 Week High
$14.22
$10.00

Technical Indicators

Market Signals
Indicator
ARVN
SSII
Relative Strength Index (RSI) 28.59 36.42
Support Level N/A N/A
Resistance Level $8.52 $4.16
Average True Range (ATR) 0.30 0.22
MACD -0.03 -0.01
Stochastic Oscillator 8.61 43.75

Price Performance

Historical Comparison
ARVN
SSII

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About SSII SS Innovations International Inc.

SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.

Share on Social Networks: